268 related articles for article (PubMed ID: 16908143)
1. Synthesis and anti-HIV-1 activity of a novel series of 1,4,2-benzodithiazine-dioxides.
Brzozowski Z; Saczewski F; Neamati N
Bioorg Med Chem Lett; 2006 Oct; 16(20):5298-302. PubMed ID: 16908143
[TBL] [Abstract][Full Text] [Related]
2. Synthesis, antitumor and anti-HIV activities of benzodithiazine-dioxides.
Brzozowski Z; Saczewski F; Neamati N
Bioorg Med Chem; 2006 May; 14(9):2985-93. PubMed ID: 16406643
[TBL] [Abstract][Full Text] [Related]
3. Synthesis, antiviral, and anti-HIV-1 integrase activities of 3-aroyl-1,1-dioxo-1,4,2-benzodithiazines.
Brzozowski Z; Saczewski F; Sanchez T; Kuo CL; Gdaniec M; Neamati N
Bioorg Med Chem; 2004 Jul; 12(13):3663-72. PubMed ID: 15186851
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and biological activity of new 2-amino-8-chloro-5,5-dioxo[1,2,4]triazolo[2,3-b][1,4,2]benzodithiazines.
Pomarnacka E; Bednarski PJ; Reszka P; Dziemidowicz-Borys E; Bieńczak A; Werel W; Hałasa R
Eur J Med Chem; 2006 May; 41(5):633-9. PubMed ID: 16488515
[TBL] [Abstract][Full Text] [Related]
5. Design and synthesis of 2-(2,6-dibromophenyl)-3-heteroaryl-1,3-thiazolidin-4-ones as anti-HIV agents.
Rawal RK; Tripathi R; Katti SB; Pannecouque C; De Clercq E
Eur J Med Chem; 2008 Dec; 43(12):2800-6. PubMed ID: 18242784
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and anti-HIV activity evaluation of novel 2,4-disubstituted 7-methyl-1,1,3-trioxo-2,4-dihydro-pyrazolo-[4,5-e][1,2]thiadiazines.
Liu XY; Yan RZ; Wang Y; Zhan P; De Clercq E; Pannecouque C; Witvrouw M; Molina MT; Vega S
Arch Pharm (Weinheim); 2008 Apr; 341(4):216-22. PubMed ID: 18266290
[TBL] [Abstract][Full Text] [Related]
7. A new type of mixed anhydride and its applications to the synthesis of 7-substituted 8-chloro-5,5-dioxoimidazo[1,2-b][1,4,2]benzodithiazines with in vitro antitumor activity.
Brzozowski Z; Saczewski F
J Med Chem; 2002 Jan; 45(2):430-7. PubMed ID: 11784147
[TBL] [Abstract][Full Text] [Related]
8. Novel potential agents for human cytomegalovirus infection: synthesis and antiviral activity evaluation of benzothiadiazine dioxide acyclonucleosides.
Martinez A; Esteban AI; Castro A; Gil C; Conde S; Andrei G; Snoeck R; Balzarini J; De Clercq E
J Med Chem; 1999 Apr; 42(7):1145-50. PubMed ID: 10197958
[TBL] [Abstract][Full Text] [Related]
9. Synthesis of N-(6-chloro-7-R-1,1-dioxo-1,4,2-benzodithiazin-3- yl)aminoacetaldehyde dimethyl acetals and their transformations into 8-chloroimidazo [1,2-b][1,4,2]benzodithiazine 5,5-dioxide derivatives with potential anti-HIV or anticancer activity.
Brzozowski Z
Acta Pol Pharm; 1997; 54(4):293-8. PubMed ID: 9511457
[TBL] [Abstract][Full Text] [Related]
10. Syntheses and anti-HIV activities of (+/-)-norcarbovir and (+/-)-norabacavir.
Huang W; Miller MJ; De Clercq E; Balzarini J
Org Biomol Chem; 2007 Apr; 5(8):1164-6. PubMed ID: 17406712
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and anti-HIV-1 integrase activities of 3-aroyl-2,3-dihydro-1,1-dioxo-1,4,2-benzodithiazines.
Brzozowski Z; Saczewski F; Sławiński J; Sanchez T; Neamati N
Eur J Med Chem; 2009 Jan; 44(1):190-6. PubMed ID: 18394758
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and anti-HIV activity of 4'-modified cyclopentenyl pyrimidine C-nucleosides.
Liu LJ; Hong JH
Nucleosides Nucleotides Nucleic Acids; 2009 Apr; 28(4):303-14. PubMed ID: 20183583
[TBL] [Abstract][Full Text] [Related]
13. Non-nucleoside HIV-1 reverse-transcriptase inhibitors. Part 10. Synthesis and anti-HIV activity of 5-alkyl-6-(1-naphthylmethyl)pyrimidin-4(3H)-ones with a mono- or disubstituted 2-amino function as novel 'dihydro-alkoxy-benzyl-oxopyrimidine' (DABO) analogues.
Wang Y; Chen FE; Balzarini J; De Clercq E; Pannecouque C
Chem Biodivers; 2008 Jan; 5(1):168-76. PubMed ID: 18205120
[TBL] [Abstract][Full Text] [Related]
14. Concise synthesis and anti-HIV activity of pyrimido[1,2-c][1,3]benzothiazin-6-imines and related tricyclic heterocycles.
Mizuhara T; Oishi S; Ohno H; Shimura K; Matsuoka M; Fujii N
Org Biomol Chem; 2012 Sep; 10(33):6792-802. PubMed ID: 22829059
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and biological investigation of S-aryl-S-DABO derivatives as HIV-1 inhibitors.
Mugnaini C; Manetti F; Esté JA; Clotet-Codina I; Maga G; Cancio R; Botta M; Corelli F
Bioorg Med Chem Lett; 2006 Jul; 16(13):3541-4. PubMed ID: 16621553
[TBL] [Abstract][Full Text] [Related]
16. Synthesis, anti-HIV and antitubercular activities of lamivudine prodrugs.
Sriram D; Yogeeswari P; Gopal G
Eur J Med Chem; 2005 Dec; 40(12):1373-6. PubMed ID: 16129516
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and evaluation of 2-(2,6-dihalophenyl)-3-pyrimidinyl-1,3-thiazolidin-4-one analogues as anti-HIV-1 agents.
Rawal RK; Tripathi R; Katti SB; Pannecouque C; De Clercq E
Bioorg Med Chem; 2007 May; 15(9):3134-42. PubMed ID: 17349793
[TBL] [Abstract][Full Text] [Related]
18. Acetylene compounds of potential pharmacological value. XL. N-(tert-aminoalkynyl)-substituted 3-isothiazolidinone-1,1-dioxides and tetrahydro-1,2-thiazin-3-one-1,1-dioxides.
Lindeke B; Dahlbom R; Ringdahl B
Acta Pharm Suec; 1987; 24(4):161-8. PubMed ID: 3439465
[No Abstract] [Full Text] [Related]
19. Synthesis and biological activity of novel acyclic versions of Neplanocin A.
Wu Y; Hong JH
Arch Pharm (Weinheim); 2005 Nov; 338(11):517-21. PubMed ID: 16281309
[TBL] [Abstract][Full Text] [Related]
20. The design, synthesis, and biological evaluation of novel substituted purines as HIV-1 Tat-TAR inhibitors.
Yuan D; He M; Pang R; Lin SS; Li Z; Yang M
Bioorg Med Chem; 2007 Jan; 15(1):265-72. PubMed ID: 17055732
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
